These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy]. Kuwabara S. Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358 [Abstract] [Full Text] [Related]
5. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome. Autore F, Innocenti I, Luigetti M, Piccirillo N, Sora F, Chiusolo P, Sica S, Bacigalupo A, Laurenti L. Hematol Oncol; 2018 Apr; 36(2):392-398. PubMed ID: 28913957 [Abstract] [Full Text] [Related]
14. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management. Dispenzieri A. Am J Hematol; 2019 Jul 12; 94(7):812-827. PubMed ID: 31012139 [Abstract] [Full Text] [Related]
15. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Kuwabara S, Dispenzieri A, Arimura K, Misawa S, Nakaseko C. Cochrane Database Syst Rev; 2012 Jun 13; 2012(6):CD006828. PubMed ID: 22696361 [Abstract] [Full Text] [Related]
16. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology]. Misawa S. Brain Nerve; 2008 Jun 13; 60(6):595-601. PubMed ID: 18567354 [Abstract] [Full Text] [Related]